BioMarin Pharmaceutical
BMRN
#1854
Rank
โ‚น992.85 B
Marketcap
โ‚น5,162
Share price
1.09%
Change (1 day)
-14.62%
Change (1 year)

Revenue for BioMarin Pharmaceutical (BMRN)

Revenue in 2025 (TTM): โ‚น281.89 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚น303.84 Billion. an increase over the revenue in the year 2024 that were of โ‚น244.82 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioMarin Pharmaceutical from 1999 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น289.16 B18.11%
2024 โ‚น244.82 B21.56%
2023 โ‚น201.39 B16.11%
2022 โ‚น173.44 B26.22%
2021 โ‚น137.42 B1%
2020 โ‚น136.06 B11.97%
2019 โ‚น121.51 B16.54%
2018 โ‚น104.26 B24.31%
2017 โ‚น83.87 B10.52%
2016 โ‚น75.89 B28.34%
2015 โ‚น59.13 B24.29%
2014 โ‚น47.58 B40.42%
2013 โ‚น33.88 B23.6%
2012 โ‚น27.41 B17.42%
2011 โ‚น23.34 B38.48%
2010 โ‚น16.86 B11.93%
2009 โ‚น15.06 B5.71%
2008 โ‚น14.25 B198.67%
2007 โ‚น4.77 B27.94%
2006 โ‚น3.72 B222.88%
2005 โ‚น1.15 B
2002 โ‚น0.66 B33.82%
2001 โ‚น0.49 B-13.3%
2000 โ‚น0.57 B89.58%
1999 โ‚น0.30 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sanofi
SNY
โ‚น5.086 T 1,573.94%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
โ‚น63.48 B-79.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น3.10 B-98.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น28.65 B-90.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น59.82 B-80.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น55.55 B-81.72%๐Ÿ‡บ๐Ÿ‡ธ USA